Lavipharm SA Sustainability Reports

Lavipharm S.A. is an integrated pharmaceutical company engaged in the research, development, production, marketing, and distribution of prescription medicines, over-the-counter drugs, and health supplements. It is globally recognized for its expertise in manufacturing Transdermal Drug Delivery Systems.

Sector: Manufacturing

Country: Greece

Exchange: Athens Stock Exchange

LEI: 213800USC69CRPRGWJ15

FIGI: BBG001S8MMN1

7 reports from 2021 to 2025

• Lavipharm SA 2025 Summary of Internal Operating Regulation
• Lavipharm SA 2025 Annual Financial Report
• Lavipharm SA 2024 Audit Committee Activities Report
• Lavipharm SA 2024 Sustainability Report
• Lavipharm SA 2023 Sustainability Report